Triglicéridos en ayunas y posprandiales, y su contribución al estudio del riesgo cardiometabólico

• Autores: J. Ildefonso Arocha Rodulfo, Carlos I. Ponte Negretti, Franklin Ablan Candia
• Localización: Clínica e investigación en arteriosclerosis, ISSN 0214-9168, ISSN-e 1578-1879, Vol. 21, Nº. 6, 2009, págs. 290-297
• Idioma: español
• Títulos paralelos:
  • Fasting or non fasting triglycerides and their contribution to the study of cardiometabolic risk
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 1 Cita
• Resumen

  • The association of triglycerides with the incidence of cardiovascular disease remains controversial; however, the evidence that elevated serum triglyceride levels are associated with increased risk for atherosclerotic events is increasing. Elevated nonfasting triglyceride levels indicate the presence of residual lipoproteins, which may promote atherosclerosis. Most patients with coronary heart disease, diabetes, obesity or metabolic syndrome have lipoprotein disorders, which include a combination of elevated triglyceride levels, small and dense LDL particles, and low levels of HDL. This is referred as the atherogenic phenotype.

    In most studies, triglyceride levels are obtained in the fasting state; however, postprandial hypertriglyceridemia may play an important role in atherosclerosis.

    The aim of this review is to determine the association between triglyceride levels (fasting vs. non-fasting) and risk of future cardiovascular events.